FLT3 and cancer: As 5-3 was designed based on plinubulin, which inhibits cancer cell growth by targeting β-tubulin, we conducted molecular docking of 5-3 with β-tubulin (PDB: 4XHC) to determine if its potency in killing FLT3-ITD mutant cells is related to β-tubulin.